NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Paperplane Therapeutics

Paperplane Therapeutics

Private
Granby, QuebecHealthcare & Life Scienceshttps://paperplanetherapeutics.com/

Last Round

Seed

Nov 1, 2024

Total Funding Raised

$1.82M

Company Overview

Paperplane Therapeutics is a healthtech company that provides virtual reality therapies intended to manage patient pain and anxiety.

Sector

Healthcare & Life Sciences

Verticals

AR/VR Experiences, Medical Devices, Patient Engagement, Mental Health

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

VR therapydigital therapeuticsDTxpain managementanxiety managementmedical VRpediatric caredrug-free pain reliefdental VRprocedural painmedtechimmersive therapyhealthtechpatient experiencehardware subscriptionsensor-guided breathing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paperplane Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Paperplane Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Paperplane Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2024
GrantAug 23, 2023

Key People

Founding team and executive leadership

Jean-Simon Fortin

Co-Founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Monthly visitors increased 71% MoM.

  • May 3, 2025

    Grew 57% QoQ from 7 to 11 employees.

Paperplane Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Paperplane Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Paperplane Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGranby, Quebec
Employee Range10
Year Founded2019
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.